AVADEL PHARMACEUTICALS PLC Quarterly Operating Margin in % from Q4 2018 to Q3 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Avadel Pharmaceuticals Plc quarterly/annual Operating Margin history and growth rate from Q4 2018 to Q3 2024.
  • Avadel Pharmaceuticals Plc Operating Margin for the quarter ending September 30, 2024 was -46.3 %.
  • Avadel Pharmaceuticals Plc annual Operating Margin for 2012 was -37.7 %, a 30.6% decline from 2011.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -46.3 Jul 1, 2024 Sep 30, 2024
Q2 2024 -104 Apr 1, 2024 Jun 30, 2024
Q1 2024 -246 Jan 1, 2024 Mar 31, 2024
Q4 2023 -493 Oct 1, 2023 Dec 31, 2023
Q1 2021 -24.8 +16 +39.3% Jan 1, 2021 Mar 31, 2021
Q4 2020 26 +66.8 Oct 1, 2020 Dec 31, 2020
Q3 2020 38.2 +172 Jul 1, 2020 Sep 30, 2020
Q2 2020 46.8 +184 Apr 1, 2020 Jun 30, 2020
Q1 2020 -40.8 +75.5 +64.9% Jan 1, 2020 Mar 31, 2020
Q4 2019 -40.7 +60.9 +59.9% Oct 1, 2019 Dec 31, 2019
Q3 2019 -133 Jul 1, 2019 Sep 30, 2019
Q2 2019 -137 Apr 1, 2019 Jun 30, 2019
Q1 2019 -116 Jan 1, 2019 Mar 31, 2019
Q4 2018 -102 Oct 1, 2018 Dec 31, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.